AMRX - Amneal Pharmaceuticals Inc - Ordinary Shares - Class A
IEX Last Trade
8.65
-0.020 -0.231%
Share volume: 964,238
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$8.67
-0.02
-0.23%
Summary score
32%
Profitability
16%
Dept financing
43%
Liquidity
57%
Performance
40%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-25.07%
Return on assets
1.31%
Return on sales
8.82%
Return on invested capital
-1.47%
Total debt ratio
92.86%
Debt ratio change over timeo
-172.48%
Current Ratio
2.04%
Quick Ratio
1.32%
Cash Position Ratio
0.28%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-87.06%
Return on assets
1.9%
Return on sales
10.9%
Return on invested capital
-3.46%
Total debt ratio
95.93%
Debt ratio change over timeo
55.77%
Current Ratio
1.76%
Quick Ratio
1.05%
Cash Position Ratio
0.1%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
143.81%
Return on assets
2.46%
Return on sales
12.92%
Return on invested capital
-7.38%
Total debt ratio
101.84%
Debt ratio change over time
-13.89%
Current Ratio
1.65%
Quick Ratio
0.97%
Cash Position Ratio
0.06%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
661.6%
Return on assets
-273.72%
Return on sales
-1379.37%
Return on invested capital
-3.11%
Total debt ratio
-17248.17%
Debt ratio change over time
-172.48%
Current Ratio
-400.95%
Quick Ratio
-260.89%
Cash Position Ratio
-55.41%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AMRX | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -25.07% | 18.83% | 17.34% | 7.6% |
| Return on assets | 1.31% | 4.16% | 8.21% | 3.22% |
| Return on sales | 8.82% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | -1.47% | 9.79% | -219.55% | 7.46% |
| Profitability | 9% | 80% | 73% | 54% |
| Total debt ratio | 92.86% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | -172.48% | -4.38% | -0.73% | -33.74% |
| Dept financing | 25% | 22% | 40% | 16% |
| Current Ratio | 1.76% | 1.12% | 0% | 1.16% |
| Quick Ratio | 1.05% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 0.1% | 0.13% | 0% | 0.52% |
| Liquididy | 62% | 41% | 44% | 60% |
| Short-term ratios | AMRX | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -87.06% | 13.31% | 0% | 13.48% |
| Return on assets | 1.9% | 4.72% | 0% | 3.05% |
| Return on sales | 10.9% | 31.4% | 0% | 25.56% |
| Return on invested capital | -3.46% | 10.68% | 0% | 13.96% |
| Profitability | 19% | 94% | 0% | 87% |
| Total debt ratio | 95.93% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | 55.77% | -41.82% | 0% | 7.13% |
| Dept financing | 50% | 21% | 0% | 19% |
| Current Ratio | 1.76% | 1.12% | 0% | 1.16% |
| Quick Ratio | 1.05% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 0.1% | 0.13% | 0% | 0.52% |
| Liquididy | 55% | 43% | 0% | 63% |